India inaugurates 1st batch of indigenous anti-COVID-19 drug
The Indian Government, on Monday, launched the first batch of its indigenous anti-COVID-19 drug, 2-deoxy-D-glucose (2-DG). The drug was developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS). INMAS, a lab of India’s Defence Research and Development Organisation (DRDO) in collaboration with Dr Reddy’s Laboratories (DRL), in the southern city Hyderabad, is used […]
The Indian Government, on Monday, launched the first batch of its indigenous anti-COVID-19 drug, 2-deoxy-D-glucose (2-DG).
The drug was developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS).
INMAS, a lab of India’s Defence Research and Development Organisation (DRDO) in collaboration with Dr Reddy’s Laboratories (DRL), in the southern city Hyderabad, is used to treat COVID-19 patients.
The first batch of the drug was handed over by the Federal Defence Minister, Rajnath Singh, to the Federal Health Minister, Harsh Vardhan, in the capital New Delhi.
The 2-DG drug was recently given approval for emergency use by the Drugs Controller General of India.
India has been hit by a devastating second wave of COVID-19 infections.
The health ministry earlier said 281,386 new cases and 4,106 related deaths were registered in the past 24 hours across the country.
